ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.5571C>G (p.Ile1857Met)

dbSNP: rs771837192
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002319640 SCV001186172 uncertain significance Hereditary cancer-predisposing syndrome; Cardiovascular phenotype 2018-11-20 criteria provided, single submitter clinical testing The p.I1836M variant (also known as c.5508C>G), located in coding exon 37 of the NF1 gene, results from a C to G substitution at nucleotide position 5508. The isoleucine at codon 1836 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV001065090 SCV001230029 uncertain significance Neurofibromatosis, type 1 2019-03-02 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with NF1-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces isoleucine with methionine at codon 1836 of the NF1 protein (p.Ile1836Met). The isoleucine residue is moderately conserved and there is a small physicochemical difference between isoleucine and methionine.
Genome-Nilou Lab RCV001065090 SCV002560884 uncertain significance Neurofibromatosis, type 1 2022-03-15 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.